5 / 8
Page 11
Notes:
allied
academies
Journal of Industrial and Environmental Chemistry| Volume: 3
February 18-19, 2019 | Paris, France
Joint Event
Green Chemistry and Technology
8
th
World Congress on
International Conference on
Organic and Inorganic Chemistry
T
he study of polymorphism in drugs is an important part of
drug development in present scenario. Infact, a detailed
drug polymorph study helps to resolve problems such as drug
solubility, drug formulation techniques in drug manufacturing
processes. The area of drug polymorphism has received
varied academic as well as industrial attention. The regulatory
approvals for filing abbreviated new drug application (ANDA)
and new drug application (NDA) of a particular dosage form
are so strict that pharma organizations are deliberately
studying polymorphs with their stability and bioavailability.
The given study identifies a new polymorph of Estradiol one
of the sleep awakening drugs in the market along with its
characterization with pXRD, DSC and TGA and its stability data.
Speaker Biography
Runjhun Tandon is in the chemistry department of Lovely Professional University as an
Associate Professor. She heads the Intellectual Property Rights Cell and take cares of the
entire IPR of the university. She has obtained her graduation
(B.Sc) and post graduation
(M.Sc) degrees from Lucknow University and her Ph.D from Rajasthan University, India.
Her research work includes synthesis of heterocyclic compounds and their polymorphic
studies. Her basic inclination is towards polymorphismof active pharmaceutical ingredients
for which she adds many patents both Indian as well as international to her credit. She has
publishedmanypapersonmetalcomplexation,polymorphism,andanticancercompounds
e:
runjhun.19532@lpu.co.inRunjhun Tandon
Lovely Professional University, India
New polymorph of Estradiol and its stability studies
Runjhun Tandon, J Ind Environ Chem 2019, Volume 3
DOI: 10.4066/2591-7331-C1-007